"Colestipol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic. It may also may reduce triglyceride levels.
Below are MeSH descriptors whose meaning is more general than "Colestipol".
Below are MeSH descriptors whose meaning is more specific than "Colestipol".
This graph shows the total number of publications written about "Colestipol" by people in this website by year, and whether "Colestipol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Colestipol" by people in Profiles.
Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study-Observational Study. J Clin Lipidol. 2016 Sep-Oct; 10(5):1091-7.
The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients. Atherosclerosis. 1995 Jan 20; 112(2):223-35.
Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy. Am J Cardiol. 1995 Jan 01; 75(1):34-9.
Treatment of familial hypercholesterolemia with drugs in children. Arteriosclerosis. 1989 Jan-Feb; 9(1 Suppl):I145-51.
Drug therapy in children and adolescents with familial hypercholesterolemia. Prog Clin Biol Res. 1988; 255:273-80.
Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. S Afr Med J. 1975 Jul 19; 49(31):1252-6.